Key result
Highest quartile serum copper-to-zinc ratio is linked to ~3.7-fold higher odds of hypertension.
Why the study?
Disturbances in trace-element homeostasis involving copper (Cu) and zinc (Zn) may contribute to hypertension (HTN) pathogenesis through their roles in antioxidant defense and vascular function. This study evaluated the association of serum Cu, Zn, and the Cu/Zn ratio with HTN among adults in Bangladesh.
Cross-Sectional (n=100)
No
Odds Ratio: 3.723
Absolute Event Rate: 1.53% vs 1.22%
p-value: p=0.043
An elevated serum copper-to-zinc ratio is positively correlated with systolic and diastolic blood pressure and is independently associated with hypertension in Bangladeshi adults aged 40 years and older, suggesting its potential utility as a marker of trace-element imbalance in hypertension.
Background: Hypertension (HTN) is a major public health problem, and disturbances in trace-element homeostasis may contribute to its pathogenesis.Copper (Cu) and zinc (Zn) are involved in antioxidant defense and vascular function, while their relative balance may be reflected by the copper-to-zinc (Cu/Zn) ratio.Objective: The aim of this study was to evaluate the association of serum Cu, Zn, and Cu/Zn ratio with HTN among adults attending Bangladesh Medical University (BMU), Dhaka.Methods: This cross-sectional comparative study was conducted in the Department of Biochemistry and Molecular Biology, BMU, among 100 adults aged ≥40 years, comprising 46 hypertensive and 54 normotensive participants recruited from the Cardiology and Medicine outpatient departments.Serum Cu and Zn levels were measured using standard spectrophotometric methods, and the Cu/Zn ratio was calculated.Lifestyle factors, excess salt intake, dyslipidemia, and body mass index were also assessed.Independent-samples t-test, Chi-square test, and Spearman's correlation analysis were used as appropriate.Binary logistic regression was performed to determine the independent association of serum Zn and Cu/Zn ratio with HTN after adjustment for dyslipidemia and excess salt intake.A p-value of <0.05 was considered statistically significant.Results: The median age was 50 years in both groups.Excess salt intake was significantly more common among hypertensive participants (27; 58.70%) than normotensive participants (19; 35.19%), p=0.019, as was dyslipidemia (23; 50.00% vs. 10; 18.52%, p=0.003).Serum Cu levels did not differ significantly between hypertensive and normotensive participants (101.42±29.12 vs. 94.14±24.92µg/dL, p=0.187).In contrast, serum Zn levels were significantly lower in the hypertensive group (63.46±19.01 vs. 73.75±24.54µg/dL, p=0.015), while the Cu/Zn ratio was significantly higher (1.53±0.61 vs. 1.22±0.49,p=0.007).Serum Zn showed significant negative correlations with systolic blood pressure (SBP) (ρ = -0.412,p<0.001) and diastolic blood pressure (DBP) (ρ = -0.210,p=0.036), whereas the Cu/Zn ratio showed significant positive correlations with SBP (ρ=0.412,p<0.001) and DBP (ρ=0.278,p=0.005).Serum Cu showed no significant correlation with either SBP or DBP.After adjustment for dyslipidemia and excess salt intake, the fourth quartile of the Cu/Zn ratio was independently associated with HTN, with approximately 3.7-fold higher odds than the first quartile (adjusted odds ratio=3.723,p=0.043), whereas serum Zn showed no independent association.Conclusion: Serum Cu was not significantly associated with HTN, whereas lower serum Zn and a higher Cu/Zn ratio were observed among hypertensive individuals.The Cu/Zn ratio showed significant correlations with both SBP and DBP and remained independently associated with HTN after adjustment for selected confounders.The Cu/Zn ratio may therefore have potential as an additional marker of trace-element imbalance in HTN; however, larger prospective studies are required to establish its clinical and causal significance.
No takes yet. Share an insight, caveat, or question.
Sharmin et al. (2026) conducted a cross-sectional in Hypertension (n=100). Serum copper-to-zinc (Cu/Zn) ratio (4th quartile) vs. Normotensive control / 1st quartile of serum Cu/Zn ratio was evaluated on Hypertension (association with serum Cu/Zn ratio) (OR 3.723, p=0.043). A fourth-quartile serum copper-to-zinc ratio was independently associated with 3.7-fold higher odds of hypertension compared to the first quartile (adjusted OR 3.723, p=0.043).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: